Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)

 Full screen view
Filter results: >>>>
Cell Small Molecule 1 Small Molecule 2 Small Mol 1 Concentration Small Mol 2 Concentration Small Mol Conc Unit Time Point Time Point Unit Replicate Total Number of Cells (Nuclei) Number of Apoptotic Cells Relative Viability Mean Relative Viability Apoptosis Fraction Mean Apoptosis Fraction
COLO 858 Vemurafenib PF562271 1.000 3.160
uM
 72
hr
 3 477 452 0.0045 0.0058 0.9476 0.9416
COLO 858 Vemurafenib Saracatinib 3.160 3.160
uM
 72
hr
 3 752 724 0.0047 0.0054 0.9628 0.9547
COLO 858 Vemurafenib Saracatinib 3.160 3.160
uM
 72
hr
 2 726 696 0.0051 0.0054 0.9587 0.9547
COLO 858 Vemurafenib Saracatinib 3.160 3.160
uM
 72
hr
 1 661 623 0.0064 0.0054 0.9425 0.9547
COLO 858 Vemurafenib Defactinib 3.160 3.160
uM
 72
hr
 1 921 884 0.0044 0.0047 0.9598 0.9535
COLO 858 Vemurafenib Defactinib 3.160 3.160
uM
 72
hr
 2 809 781 0.0033 0.0047 0.9654 0.9535
COLO 858 Vemurafenib Defactinib 3.160 3.160
uM
 72
hr
 3 850 795 0.0065 0.0047 0.9353 0.9535
COLO 858 Vemurafenib PF562271 3.160 3.160
uM
 72
hr
 2 424 402 0.0040 0.0041 0.9481 0.9488
COLO 858 Vemurafenib PF562271 3.160 3.160
uM
 72
hr
 1 486 455 0.0056 0.0041 0.9362 0.9488
COLO 858 Vemurafenib PF562271 3.160 3.160
uM
 72
hr
 3 422 406 0.0029 0.0041 0.9621 0.9488